The news of Lisa Faulkner's cancer diagnosis, shared by her husband John Torode, brings into sharp focus a grim reality for hundreds of thousands across the UK: a cancer diagnosis isn't just a medical battle; it's a significant financial one. While the NHS provides treatment, the associated costs can be crippling, with the average patient facing an additional £891 per month in expenses.
The Unseen Bill: Financial Toxicity in the UK
This isn't a minor inconvenience; it's a systemic issue. Data indicates that 83% of people with cancer in the UK experience some form of financial impact. For those severely affected, which accounts for more than one in three (39%) of patients, this monthly burden can exceed £1,000, reaching an average of £1,038. This phenomenon, dubbed 'financial toxicity', impacts 34% of UK cancer patients, forcing them into material hardship, emotional distress, and even difficult coping strategies such as skipping medication or cutting back on essentials.
The financial strain manifests in multiple ways. Over half (54%) of patients report an increase in day-to-day living costs. This includes a significant 28% facing extra travel costs for appointments – a necessity, not a luxury – and 17% grappling with higher household fuel bills, often due to increased time spent at home during recovery or treatment.
Income Erosion: A Double Whammy
Compounding these rising costs is a substantial loss of income. Three-quarters (75%) of people with cancer suffer a reduction in their earnings. The average income reduction stands at 17.4%, but for those already in precarious financial positions, the impact is far more severe. Low-income groups can see their income plummet by as much as 42.9%, while low-education groups face a 32.9% reduction. This isn't merely a statistic; it's the difference between managing and spiralling into debt.
"The number of people economically inactive because of long-term sickness has risen to over 2.5 million people, an increase of over 400,000 since the start of the coronavirus (COVID-19) pandemic."
— Office for National Statistics (ONS), July 2023
The ONS has highlighted a concerning trend: economic inactivity due to long-term sickness has been on a steady ascent. From 2.5 million people in early 2023, it reached a record high of 2.8 million people in December 2023 to February 2024, representing 7% of the working-age population. This isn't solely cancer-related, but cancer is a significant contributor to this broader economic malaise.
The Broader Economic Ripple Effect
The financial impact of cancer extends far beyond individual households. The UK economy loses an estimated £10.3 billion each year due to people dying of cancer, a figure higher than any other health condition. This calculation accounts for the economic contribution individuals would have made through work had their lives not been cut short. Cancer deaths among those under 50 alone lead to an annual loss of 119,000 years of productive life and a £3.2 billion loss for the economy. The inability to work due to cancer costs the UK economy an estimated £1-1.7 billion annually, with informal caregiving adding a further £4-4.5 billion.
Scenario: The £891 Monthly Reality
Consider 'Sarah', a higher-rate taxpayer earning £60,000 annually. A cancer diagnosis means she might face an average income reduction of 17.4%, losing approximately £10,440 per year, or £870 per month. On top of this, she's likely to incur the average £891 per month in extra costs for travel, heating, and other incidentals. Combined, this represents a monthly deficit of £1,761. Over a year, this could amount to over £21,000, rapidly depleting any emergency savings not held in tax-efficient wrappers.
What this means for you
If you or someone you know receives a cancer diagnosis, the immediate priority is health. However, a parallel, urgent task is to review your financial situation. This means understanding your employment rights, exploring available benefits, and assessing your savings. Many advisers recommend having at least three to six months' worth of essential expenses readily accessible. For larger sums, consider tax-efficient savings vehicles. A Cash ISA allows you to save up to £20,000 per tax year completely tax-free. For first-time buyers under 40, a Lifetime ISA offers a 25% government bonus on contributions up to £4,000 per year, meaning a potential £1,000 bonus annually. For interest earned on standard savings accounts, remember your Personal Savings Allowance: £1,000 for basic rate taxpayers and £500 for higher rate taxpayers. Interest above these thresholds is taxable, making ISAs a prudent choice for substantial savings.
Government Response: The National Cancer Plan
Recognising the multifaceted impact of cancer, the government launched its National Cancer Plan in February 2026. This initiative aims to provide every cancer patient with a personalised plan that extends beyond medical treatment to cover the full spectrum of their life, including anxiety, fatigue, diet, and crucial support for returning to work. A new employer partnership is also part of the plan, designed to support England's 830,000 working-age cancer patients in remaining employed during and after treatment.
But there are risks
While personalised plans and employer partnerships are welcome, the implementation and immediate impact remain critical. The ONS data on economic inactivity shows a persistent challenge, suggesting that systemic support needs to be robust and swift. Furthermore, the average delay in receiving Personal Independence Payment (PIP) for cancer patients stands at 22 weeks. This significant waiting period can exacerbate financial hardship precisely when support is most needed, highlighting a gap between policy intent and practical relief.
Step-by-step what to do right now
- Review your finances: Document all income, outgoings, and any existing savings or insurance policies.
- Check benefit eligibility: Explore government benefits like Personal Independence Payment (PIP), Employment and Support Allowance (ESA), and Universal Credit.
- Contact your employer: Understand your sick pay policy, flexible working options, and any support programmes available.
- Seek financial advice: Consult an independent financial adviser to discuss managing your savings, potential income protection, and tax-efficient options like ISAs.
- Access support services: Charities often provide practical and financial guidance specifically for cancer patients.
When Effective
The National Cancer Plan, including personalised cancer plans and employer partnerships, was published and became effective from 4 February 2026. However, the benefits application process for PIP and other support schemes has its own timelines, with PIP delays averaging 22 weeks.
Where to get help
Organisations such as Macmillan Cancer Support, Cancer Research UK, and Citizens Advice offer comprehensive guidance on financial support and benefits for cancer patients. Your local NHS trust or GP can also signpost you to relevant services.
Sources
- Cancer Research UK — Cancer prevalence and incidence statistics
- Macmillan Cancer Support — Financial impact on individuals, 'financial toxicity' statistics, income reduction, increased living costs, PIP delays
- Office for National Statistics (ONS) — Economic inactivity data (Q1 2023, July 2023, Dec 2023-Feb 2024), long-term health conditions
- GOV.UK (National Cancer Plan) — Details of the government's plan, personalised cancer plans, employer partnership (published 4 February 2026)
This is not financial advice. Seek independent financial guidance. Interest on standard accounts may be subject to tax above your Personal Savings Allowance.